ENGINEERING MEDICINES TO IMPROVE PATIENT CARE Investors SEC Filing Details Document Details Form 3 Filing Date February 7, 2023 Document Date February 6, 2023 Form Description Initial filing by director officer or owner of more than ten percent. Filing Group 3,4,5 Company Viridian Therapeutics Inc. Issuer VIRIDIAN THERAPEUTICS, INC.\DE Filer Myers Scott Dunseth Filing Formats View HTML Download PDF Download DOC Download XLS
Document Details Form 3 Filing Date February 7, 2023 Document Date February 6, 2023 Form Description Initial filing by director officer or owner of more than ten percent. Filing Group 3,4,5 Company Viridian Therapeutics Inc. Issuer VIRIDIAN THERAPEUTICS, INC.\DE Filer Myers Scott Dunseth Filing Formats View HTML Download PDF Download DOC Download XLS